C1 Esterase Inhibitor, human
ATC (Anatomical Therapeutic Chemical Classification)
B06AC01
Therapeutic Categories
Hemostatic agent: Antifibrinolytic
Protease inhibitor
Treatment of hereditary angioedema
Chemical Name
C₁-inhibitor, human
Foreign Names
- Humaner C1-Esterase-Inhibitor (German)
- Inhibidor de C1 esterasa, humana (Spanish)
Generic Names
- Complement C1 esterase inhibitor (IS)
- UNII-6KIC4BB60G (IS)
- C1-INH (IS)
- UNII-5QS67N4551 (IS)
Brand Names
- Berinert
CSL Behring, Austria; CSL Behring, Belgium; CSL Behring, Canada; CSL Behring, Switzerland; CSL Behring, Germany; CSL Behring, Finland; CSL Behring, France; CSL Behring, United Kingdom; CSL Behring, Greece; CSL Behring, Hungary; CSL Behring, Italy; CSL Behring, Japan; CSL Behring, Netherlands; CSL Behring, Norway; CSL Behring, Sweden; CSL Behring, Slovenia; CSL Behring, Slovakia; CSL Behring, United States; ZLB Behring, Bulgaria - Berinert P
Csl Behring, Spain - Berinert P Behring
CSL Behring, Austria - Cetor
Centurion Pharma, Turkey; Sanquin, Netherlands - Cinryze
Lev, United States; Sanquin, Netherlands; ViroPharma Limited, United Kingdom - Ruconest
Pharming Group, Norway; Swedish Orphan, Germany; Swedish Orphan, United Kingdom; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, Sweden
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
